Celgene to acquire Abraxis BioScience for $58 a share plus 0.2617 shares of Celgene stock, or about $2.9 billion, net of ... http://wsj.com
3:07 AM - 30 Jun 2010
0 replies
8 retweets
2 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.